WallStreetZenWallStreetZen

NASDAQ: CTKB
Cytek Biosciences Inc Stock

$8.49+0.04 (+0.47%)
Updated Feb 22, 2024
CTKB Price
$8.49
Fair Value Price
-$1.53
Market Cap
$1.15B
52 Week Low
$3.80
52 Week High
$12.31
P/E
-84.9x
P/B
2.77x
P/S
4.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$183.12M
Earnings
-$14.12M
Gross Margin
57.8%
Operating Margin
-7.39%
Profit Margin
-7.7%
Debt to Equity
0.25
Operating Cash Flow
$2M
Beta
1.49
Next Earnings
Feb 28, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CTKB Overview

Cytek Biosciences, Inc. provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. Its core instruments, the Aurora and Northern Lights systems, are spectrum flow cytometers. The company sells its instruments in the U.S. and internationally. Cytek Biosciences was founded in 1992 and is headquartered in Fremont, CA.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CTKB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CTKB ($8.49) is overvalued by 655.89% relative to our estimate of its Fair Value price of -$1.53 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CTKB ($8.49) is not significantly undervalued (655.89%) relative to our estimate of its Fair Value price of -$1.53 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CTKB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CTKB due diligence checks available for Premium users.

Be the first to know about important CTKB news, forecast changes, insider trades & much more!

CTKB News

Valuation

CTKB fair value

Fair Value of CTKB stock based on Discounted Cash Flow (DCF)
Price
$8.49
Fair Value
-$1.53
Undervalued by
655.89%
CTKB ($8.49) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CTKB ($8.49) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CTKB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CTKB price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-84.9x
Industry
36.93x
Market
31.94x

CTKB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.77x
Industry
4.06x
CTKB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CTKB's financial health

Profit margin

Revenue
$48.0M
Net Income
-$6.5M
Profit Margin
-13.5%
CTKB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CTKB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$519.4M
Liabilities
$103.9M
Debt to equity
0.25
CTKB's short-term assets ($422.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CTKB's short-term assets ($422.32M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CTKB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.2M
Investing
$43.1M
Financing
-$8.3M
CTKB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CTKB vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
CTKB$1.15B+0.47%-84.90x2.77x
FNA$1.10B-2.06%-15.64x5.67x
AHCO$1.03B+5.92%-2.36x0.59x
QTRX$965.04M-1.05%-25.01x2.73x
ESTA$948.71M+2.68%-13.13x31.12x

Cytek Biosciences Stock FAQ

What is Cytek Biosciences's quote symbol?

(NASDAQ: CTKB) Cytek Biosciences trades on the NASDAQ under the ticker symbol CTKB. Cytek Biosciences stock quotes can also be displayed as NASDAQ: CTKB.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.

What is the 52 week high and low for Cytek Biosciences (NASDAQ: CTKB)?

(NASDAQ: CTKB) Cytek Biosciences's 52-week high was $12.31, and its 52-week low was $3.80. It is currently -31.03% from its 52-week high and 123.42% from its 52-week low.

How much is Cytek Biosciences stock worth today?

(NASDAQ: CTKB) Cytek Biosciences currently has 135,549,154 outstanding shares. With Cytek Biosciences stock trading at $8.49 per share, the total value of Cytek Biosciences stock (market capitalization) is $1.15B.

Cytek Biosciences stock was originally listed at a price of $18.76 in Jul 23, 2021. If you had invested in Cytek Biosciences stock at $18.76, your return over the last 2 years would have been -54.74%, for an annualized return of -32.73% (not including any dividends or dividend reinvestments).

How much is Cytek Biosciences's stock price per share?

(NASDAQ: CTKB) Cytek Biosciences stock price per share is $8.49 today (as of Feb 22, 2024).

What is Cytek Biosciences's Market Cap?

(NASDAQ: CTKB) Cytek Biosciences's market cap is $1.15B, as of Feb 23, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cytek Biosciences's market cap is calculated by multiplying CTKB's current stock price of $8.49 by CTKB's total outstanding shares of 135,549,154.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.